Pretest - Tumor Board Tuesday (ID: i788)

Last name:

ZIP/Postal Code:

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Potential benefit from platinum-based chemotherapy and PARP inhibitors

Potential benefit from blockade of the HER pathway

Potential benefit from immune checkpoint blockade

Potential benefit from larotrectinib/entrectinib

20%

10%

0.2%